Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui BBCA Biochemical is a prominent Chinese industrial biotechnology and pharmaceutical conglomerate based in Bengbu, Anhui. The company is globally recognized as a leading producer of citric acid, amino acids, and other fermentation-based biochemicals used in the food and healthcare sectors. Through its extensive pharmaceutical operations, it manufactures a diverse portfolio of active pharmaceutical ingredients (APIs) and finished drug products, including antibiotics and cardiovascular medications. BBCA is also a major supplier of intravenous infusions and is heavily involved in the production of bio-based materials like polylactic acid (PLA). The company integrates R&D, large-scale manufacturing, and international trade to serve the global healthcare, food, and chemical industries. It maintains a strong focus on sustainable green chemistry and bio-manufacturing technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui BBCA Biochemical.